The complainant has requested information about the Chimeric Antigen Receptors T-cell Therapy tariff. NHS England disclosed some information and withheld the remainder under section 41(1) of FOIA, which concerns information provided in confidence. The Commissioner’s decision is that section 41(1) has been correctly applied and he doesn’t require any further steps.